| |
| Linear PEI-based Charge-reversal Drug Conjugate for Targeted Cancer Cell Nuclear Drug Delivery |
|
|
ZHOU Zhuxian 1,TANG Jianbin 2,SHEN Youqing 2 *
|
|
|
1.Center for Bionanoengineering and State Key Laboratory of Chemical Engineering, Department of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310027, China; Department of Chemical and Petroleum Engineering, University of Wyoming, Laramie 82071, USA
|
|
2.Center for Bionanoengineering and State Key Laboratory of Chemical Engineering, Department of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310027, China
|
|
| *Correspondence author |
| #Submitted by |
|
| Subject: |
| Funding:
The National Natural Science Foundation Key Program（No.21090352, 51390481）, The National Basic Research Program（No.2014CB931900）, The Doctoral Fund of Ministry of Education of China（No.20110101130007） |
| Opened online:26 December 2014 |
| Accepted by:
none |
| Citation: ZHOU Zhuxian,TANG Jianbin,SHEN Youqing.Linear PEI-based Charge-reversal Drug Conjugate for Targeted Cancer Cell Nuclear Drug Delivery[OL]. [26 December 2014] http://en.paper.edu.cn/en_releasepaper/content/4624499 |
|
